$329.3 arrow  Change: -7.77 %Chge: -2.31% Vol: 88,697
End Of Day Prices
High: 335.05 | Low: 328.65 | Open: 335.05 | Close: 329.3
52 Wk High: 348.65 | 52 Wk Low: 244.42 | Todays Pivot: 331.00
Sector: Healthcare and Pharmaceuticals add stock to watch list

BIIB Chart

You need Flash Player to see the chart, please download from the link below

Get Adobe Flash player

Related Healthcare and Pharmaceuticals Companies

Cardinal Health 74.82 green arrow 187,792
Community Health Sys Newco 37.92 red arrow 1,269,200
Steris 82.31 green arrow 14,008
Intuitive Surgical 570.81 green arrow 23,622
Regeneron Pharmaceuticals 232.08 red arrow 98,633
Patterson Companies 46.48 red arrow 61,410
Resmed 50.74 red arrow 57,635
Techne 95 red arrow 25,250

Above is a small selection of related companies to Biogen Idec which compete alongside BIIB within the Healthcare and Pharmaceuticals sector. To see more related companies to BIIB, view our stock market today information page.

Online News For Biogen Idec

Biogen (BIIB) Earnings Growth Hampers Rating

Portfolio Grader currently ranks Biogen Inc (NASDAQ:BIIB) a Hold. Using Louis Navellier's investing methodology, this analytical tool researches stocks by employing proprietary fundamental and quantitative metrics. The current Portfolio Grader ...

Biogen Inc. (BIIB) Dips 2.82% for October 23

Among the S&P 500’s biggest fallers on Monday October 23 was Biogen Inc. (BIIB). The stock experienced a 2.82% decline to $328.55 with 1.88 million shares changing hands. Biogen Inc. started at an opening price of 335.25 and hit a high of $335.51 and a ...

Biogen Inc. (BIIB) Moves Lower on Volume Spike for October 23

Biogen Inc. (BIIB) traded on unusually high volume on Oct. 23, as the stock lost 2.82% to close at $328.55. On the day, Biogen Inc. saw 1.88 million shares trade hands on 22,680 trades. Considering that the stock averages only a daily volume of 1.22 ...

Biogen Idec Inc. (NDAQ:BIIB) has been downgraded from Buy to Neutral in a statement by Citigroup today.

Yesterday Biogen Idec Inc. (NDAQ:BIIB) traded -2.13% lower at $329.99. The company’s 50-day moving average is $324.65 and its 200-day moving average is $285.82. The last closing price is up 15.77% from the 200-day moving average, compared to the S&P 500 ...

Biogen (NASDAQ:BIIB) has been downgraded from Buy to Neutral in a statement by Citigroup earlier today.

Citigroup has downgraded Biogen (NASDAQ:BIIB) from Buy to Neutral in a statement released on Monday October 23, 2017. Previously on 10/17/2017, Mizuho Securities released a statement about Biogen (NASDAQ:BIIB) increased the target price from $319.00 to $ ...

Want To Add This Quote To Your Site?

With our stock widgets you can add a Biogen Idec quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for BIIB to choose from. Visit here to build your stock quote widget »